Balance Sheet Data

EyePoint Pharmaceuticals, Inc. (EYPT)

$28.22

-0.45 (-1.57%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 38.7822.2144.91211.56144.56550.521,481.213,985.3010,722.7128,850.16
Total Cash (%)
Account Receivables 0.3511.729.4518.3515.5041.01110.33296.85798.712,148.97
Account Receivables (%)
Inventories -0.352.145.343.622.896.8718.4849.73133.81360.02
Inventories (%)
Accounts Payable 6.6611.384.817.395.9273.33197.31530.871,428.353,843.06
Accounts Payable (%)
Capital Expenditure -0.11-0.21-0.36-0.16-2.15-2.53-6.81-18.32-49.30-132.63
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.